Related Experiment Videos
Pharmacological strategies in depression.
British Journal of Hospital Medicine
|September 1, 1985
Summary
When initial antidepressant therapy fails, several options exist. Strategies include adjusting dosage, duration, or using combinations like lithium-antidepressant or adding triiodothyronine, tryptophan, anticonvulsants, or vanadium inactivators.
Area of Science:
- Pharmacology
- Neuroscience
- Psychiatry
Background:
- First-line antidepressant treatment failure is common.
- Optimizing dosage and duration is crucial for treatment success.
Purpose of the Study:
- To evaluate pharmacological strategies for patients with treatment-resistant depression.
- To review evidence for various augmentation and combination therapies.
Main Methods:
- Literature review of pharmacological interventions for antidepressant non-responders.
- Evaluation of evidence for combined antidepressants, lithium-antidepressant combinations, and other agents.
Main Results:
- Evidence supports several adjunctive treatments when initial antidepressant trials are unsuccessful.
- Specific strategies evaluated include triiodothyronine, tryptophan, anticonvulsants, and vanadium inactivators.
Conclusions:
- Multiple pharmacological options can be considered following initial antidepressant treatment failure.
- Adequate dosage and duration remain paramount in all treatment approaches.